This announcement is a milestone.There will be news of the approval of MSB stem cell therapy in China, the United States, Australia, Germany, and Japan.You know, MSB has close partners in Europe, Japan and China.
This is how I personally interpret this announcement.
The world is panicked in the face of this epidemic.MSB mature data and IP treatment methods will quickly be supported by various countries
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-40
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |